Mark Massaro Analyst PerformanceManaging Director, Senior Equity Research Analyst at BTIG ResearchMark Massaro is a stock analyst at BTIG Research focused in the healthcare sector, covering 33 publicly traded companies. Over the past year, Mark Massaro has issued 99 stock ratings, including buy, hold, and sell recommendations. While full access to Mark Massaro's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mark Massaro's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings283 Last 11 YearsBuy Recommendations90.61% 251 Buy RatingsCompanies Covered33 Unique Companies Ratings Distribution277RatingsDistribution of strong buy, buy, hold, and sell ratings by Mark Massaro.RatingPercentageCount Strong Buy0.0%0 ratings Buy90.6%251 ratings Hold8.7%24 ratings Sell0.7%2 ratingsOut of 277 total stock ratings issued by Mark Massaro at BTIG Research, the majority (90.6%) have been Buy recommendations, followed by 8.7% Hold and 0.7% Sell.Best & Worst CallsBest Call0000.0%TTOOFeb 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%WGSJan 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ78.8% of companies on NASDAQ26 companiesNYSE15.2% of companies on NYSE5 companiesOTCMKTS6.1% of companies on OTCMKTS2 companiesMark Massaro, an analyst at BTIG Research, currently covers 33 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare32 companies97.0%Miscellaneous1 company3.0%Mark Massaro of BTIG Research specializes in stock coverage within the Healthcare sector, with additional focus on companies.Coverage IndustriesIndustryPercentageHEALTHCARE PROVIDERS & SERVICES8 companies24.2%HEALTHCARE EQUIPMENT & SUPPLIES8 companies24.2%LIFE SCIENCES TOOLS & SERVICES7 companies21.2%BIOTECHNOLOGY5 companies15.2%HEALTHCARE TECHNOLOGY2 companies6.1%Miscellaneous1 company3.0%PHARMACEUTICALS1 company3.0%DIAGNOSTIC SUBSTANCES1 company3.0% About Mark MassaroMark Massaro is a Managing Director and BTIG Life Science and Diagnostic Tools Analyst. Prior to BTIG, he served as the Chief Financial Officer at ArcherDX, Inc., an oncology diagnostics and pharmaceutical services company, which was acquired by Invitae Corporation. Previously, Mr. Massaro was a Managing Director and Senior Equity Research Analyst within Diagnostics and Life Science Tools at Canaccord Genuity, where he spent more than eight years focused on high-growth, precision medicine and next-generation sequencing companies, as well as molecular and point-of-care diagnostics, reference labs and animal health. He was named a “Rising Star” in Institutional Investor’s All America Survey for life science and diagnostics tools in October 2016. Earlier in his career, Mr. Massaro was an Associate Equity Analyst within Healthcare Services at Avondale Partners and held corporate finance and financial reporting roles at Dell EMC and Fidelity Investments. He earned an MBA from Babson College and a BA in economics and Spanish from the University of Massachusetts – Amherst.Follow on LinkedIn Mark Massaro's Ratings History at BTIG Research Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsMDXHMDxHealth8/21/2026Lower Price Target$0.72$2.00Buy$0.0000.00% ROITEMTempus AI8/20/2026Boost Price Target$61.25$80.00Buy$0.0000.00% ROIFRNMFreenome8/17/2026Initiated Coverage$11.56$17.00Buy$0.0000.00% ROILUCDLucid Diagnostics8/17/2026Reiterated Rating$0.97$2.50Buy$0.0000.00% ROIFRNMFreenome8/17/2026Initiated Coverage$13.00$17.00Buy$0.0000.00% ROITKNOAlpha Teknova8/11/2026Upgrade$6.72$8.00Buy$0.0000.00% ROINTRANatera8/7/2026Boost Price Target$265.38$320.00Buy$0.0000.00% ROICAICaris Life Sciences8/6/2026Boost Price Target$20.00$33.00Buy$0.0000.00% ROIBLLNBilliontoone8/6/2026Lower Price Target$149.97$130.00Buy$0.0000.00% ROICDNACareDx8/6/2026Boost Price Target$45.50$60.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. SOPHSOPHiA GENETICS8/5/2026Boost Price Target$6.84$9.00Buy$0.0000.00% ROIXGNExagen8/5/2026Boost Price Target$6.45$9.00Buy$0.0000.00% ROIWGSGeneDx8/4/2026Reiterated Rating$67.86$90.00Buy$0.0000.00% ROICSTLCastle Biosciences8/3/2026Boost Price Target$28.00$44.00Buy$0.0000.00% ROITEMTempus AI8/3/2026Lower Price Target$46.74$70.00Buy$0.0000.00% ROIGHGuardant Health7/31/2026Boost Price Target$152.35$195.00Buy$0.0000.00% ROIADPTAdaptive Biotechnologies7/30/2026Boost Price Target$22.56$25.00Buy$0.0000.00% ROIPSNLPersonalis7/20/2026Boost Price Target$13.68$16.25Buy$0.0000.00% ROICDNACareDx7/16/2026Boost Price Target$37.31$45.00Buy$0.0000.00% ROICAICaris Life Sciences7/2/2026Reiterated Rating$18.75$32.00Buy$0.0000.00% ROIGHGuardant Health7/1/2026Boost Price Target$165.84$190.00Buy$0.0000.00% ROINTRANatera6/24/2026Set Price Target$260.53$275.00Buy$0.0000.00% ROINTRANatera6/23/2026Boost Price Target$235.22$270.00Buy$0.0000.00% ROIADPTAdaptive Biotechnologies6/17/2026Reiterated Rating$16.79$22.00Buy$0.0000.00% ROISOPHSOPHiA GENETICS6/15/2026Reiterated Rating$4.88$8.00Buy$0.0000.00% ROITEMTempus AI6/1/2026Reiterated Rating$50.47$80.00Buy$0.0000.00% ROIGHGuardant Health5/27/2026Set Price Target$125.59$160.00Buy$0.0000.00% ROIGHGuardant Health5/26/2026Boost Price Target$118.95$155.00Buy$0.0000.00% ROILUCDLucid Diagnostics5/15/2026Reiterated Rating$1.02$2.50Buy$0.0000.00% ROIMDXHMDxHealth5/14/2026Lower Price Target$1.95$4.00Buy$0.0000.00% ROICSTLCastle Biosciences5/13/2026Lower Price Target$18.63$40.00Buy$0.0000.00% ROIXGNExagen5/12/2026Lower Price Target$3.98$8.00Buy$0.0000.00% ROIPSNLPersonalis5/11/2026Lower Price Target$5.98$11.00Buy$0.0000.00% ROINTRANatera5/11/2026Lower Price Target$200.24$250.00Buy$0.0000.00% ROICAICaris Life Sciences5/8/2026Lower Price Target$19.84$32.00Buy$0.0000.00% ROITEMTempus AI5/8/2026Lower Price Target$49.02$80.00Buy$0.0000.00% ROIBLLNBilliontoone5/7/2026Lower Price Target$81.40$130.00Buy$0.0000.00% ROIADPTAdaptive Biotechnologies5/6/2026Reiterated Rating$13.78$22.00Buy$0.0000.00% ROISOPHSOPHiA GENETICS5/6/2026Reiterated Rating$5.07$8.00Buy$0.0000.00% ROIWGSGeneDx5/5/2026Lower Price Target$67.93$90.00Buy$0.0000.00% ROII found Rolls-Royce at $2 - now I see the same setup again (Ad)In 2022, Karim Rahemtulla recommended Rolls-Royce under $2 - a misunderstood aerospace name the market had written off. The stock climbed more than 1,100% over the next 3-4 years, with some subscribers reporting gains of $141,000, $272,000, or more. He believes a similar setup is forming now around what he calls the 'Energy Cube' - a compact nuclear system roughly the size of a shipping container, capable of powering up to 1,000 homes with no emissions, 24 hours a day. Bill Gates, Jeff Bezos, Google, and Microsoft have all backed companies in this space. The Nuclear Regulatory Commission is expected to issue a key approval as early as August - the first of its kind for this technology class in over a decade.Watch the full presentation before the NRC decision arrivesCERSCerus5/1/2026Upgrade$2.03$4.00Buy$0.0000.00% ROICDNACareDx4/29/2026Boost Price Target$21.91$28.00Buy$0.0000.00% ROISOPHSOPHiA GENETICS4/15/2026Boost Price Target$4.96$8.00Buy$0.0000.00% ROILUCDLucid Diagnostics3/30/2026Reiterated Rating$1.12$2.50Buy$0.0000.00% ROIEXASExact Sciences3/24/2026Reiterated Rating$104.91Neutral$0.0000.00% ROIDNAGinkgo Bioworks3/12/2026Lower Price Target$6.84$5.00Sell$0.0000.00% ROIXGNExagen3/10/2026Lower Price Target$3.33$9.00Buy$0.0000.00% ROIBLLNBilliontoone3/5/2026Lower Price Target$80.83$140.00Buy$0.0000.00% ROISOPHSOPHiA GENETICS3/3/2026Reiterated Rating$4.04$7.00Buy$0.0000.00% ROICAICaris Life Sciences2/27/2026Lower Price Target$19.24$38.00Buy$0.0000.00% ROIZTSZoetis2/26/2026Reiterated Rating$129.15$160.00Buy$0.0000.00% ROICDNACareDx2/25/2026Boost Price Target$18.46$26.00Buy$0.0000.00% ROITEMTempus AI2/25/2026Lower Price Target$57.95$90.00Buy$0.0000.00% ROIWGSGeneDx2/24/2026Lower Price Target$87.08$170.00Buy$0.0000.00% ROIGHGuardant Health2/20/2026Boost Price Target$106.38$145.00Buy$0.0000.00% ROIXGNExagen2/17/2026Lower Price Target$3.28$10.00Buy$0.0000.00% ROIPSNLPersonalis2/11/2026Boost Price Target$8.90$13.00Buy$0.0000.00% ROIADPTAdaptive Biotechnologies2/6/2026Boost Price Target$16.47$22.00Buy$0.0000.00% ROIIDXXIDEXX Laboratories2/3/2026Lower Price Target$639.60$800.00Buy$0.0000.00% ROIPSNLPersonalis1/9/2026Reiterated Rating$8.38$12.00Buy$0.0000.00% ROIMDXHMDxHealth12/23/2025Reiterated Rating$3.40$7.00Buy$0.0000.00% ROIGHGuardant Health12/12/2025Boost Price Target$101.38$140.00Buy$0.0000.00% ROIWGSGeneDx12/12/2025Boost Price Target$155.37$200.00Buy$0.0000.00% ROICSTLCastle Biosciences12/12/2025Boost Price Target$37.97$50.00Buy$0.0000.00% ROIBLLNBilliontoone12/10/2025Reiterated Rating$109.53$160.00Buy$0.0000.00% ROINTRANatera12/5/2025Boost Price Target$244.55$260.00Buy$0.0000.00% ROIZTSZoetis12/3/2025Reiterated Rating$124.44$160.00Buy$0.0000.00% ROIBLLNBilliontoone12/1/2025Initiated Coverage$130.18$160.00Buy$0.0000.00% ROIBLLNBilliontoone12/1/2025Initiated Coverage$113.04$160.00Buy$0.0000.00% ROITEMTempus AI11/25/2025Boost Price Target$76.06$105.00Buy$0.0000.00% ROIEXASExact Sciences11/20/2025Downgrade$100.99Neutral$0.0000.00% ROIMDXHMDxHealth11/13/2025Boost Price Target$4.12$7.00Buy$0.0000.00% ROIZTSZoetis11/12/2025Lower Price Target$120.09$160.00Buy$0.0000.00% ROIPSNLPersonalis11/11/2025Boost Price Target$8.63$12.00Buy$0.0000.00% ROIXGNExagen11/10/2025Boost Price Target$9.56$15.00Buy$0.0000.00% ROISOPHSOPHiA GENETICS11/10/2025Boost Price Target$4.37$7.00Buy$0.0000.00% ROINTRANatera11/7/2025Boost Price Target$198.48$230.00Buy$0.0000.00% ROIADPTAdaptive Biotechnologies11/6/2025Boost Price Target$15.56$21.00Buy$0.0000.00% ROICDNACareDx11/6/2025Boost Price Target$16.53$25.00Buy$0.0000.00% ROITEMTempus AI11/5/2025Reiterated Rating$84.49$96.00Buy$0.0000.00% ROICSTLCastle Biosciences11/4/2025Boost Price Target$31.63$38.00Buy$0.0000.00% ROIIDXXIDEXX Laboratories11/4/2025Boost Price Target$722.94$830.00Buy$0.0000.00% ROIEXASExact Sciences11/4/2025Boost Price Target$66.98$85.00Buy$0.0000.00% ROIGHGuardant Health10/30/2025Boost Price Target$72.27$100.00Buy$0.0000.00% ROIWGSGeneDx10/29/2025Boost Price Target$137.47$165.00Buy$0.0000.00% ROINTRANatera10/23/2025Boost Price Target$192.51$210.00Buy$0.0000.00% ROITEMTempus AI10/22/2025Boost Price Target$89.10$96.00Buy$0.0000.00% ROIPSNLPersonalis10/22/2025Boost Price Target$9.57$11.00Buy$0.0000.00% ROIWGSGeneDx10/22/2025Boost Price Target$121.77$140.00Buy$0.0000.00% ROIXGNExagen10/22/2025Boost Price Target$11.69$13.00Buy$0.0000.00% ROISilicon Valley Insider: "Forget AI Stocks" (Ad)A 25-year Silicon Valley veteran who recommended Nvidia before its 32,000 percent run says the next wave of AI gains wont come from Nvidia, Tesla, or SpaceX. He points to a detail buried on page 37 of the SpaceX IPO filing, tied to Elon Musks plans for 1 million AI satellites, 1 billion humanoid robots, and 200 billion AI chips a year. He says one overlooked sector could benefit most from this spending, and has identified a company trading under $1 that may factor into Musks supply chain.Watch the strategy session breaking down this overlooked sector nowEXASExact Sciences10/22/2025Boost Price Target$63.41$75.00Buy$0.0000.00% ROIADPTAdaptive Biotechnologies10/22/2025Boost Price Target$17.35$19.00Buy$0.0000.00% ROIGHGuardant Health9/25/2025Set Price Target$61.04$80.00$0.0000.00% ROICDNACareDx9/23/2025Reiterated Rating$14.99$22.00Buy$0.0000.00% ROIGHGuardant Health9/22/2025Reiterated Rating$59.15$70.00Buy$0.0000.00% ROICDNACareDx9/12/2025Reiterated Rating$13.53$22.00Buy$0.0000.00% ROILUCDLucid Diagnostics9/5/2025Boost Price Target$1.38$2.50Buy$0.0000.00% ROIGHGuardant Health9/4/2025Boost Price Target$59.08$70.00Buy$0.0000.00% ROIDNAGinkgo Bioworks8/25/2025Boost Price Target$12.51$9.00Sell$0.0000.00% ROITEMTempus AI8/20/2025Boost Price Target$73.08$85.00Buy$00.0000.00% ROIEXASExact Sciences8/12/2025Lower Price Target$41.52$60.00Buy$0.0000.00% ROIMXCTMaxCyte8/11/2025Reiterated Rating$1.38Neutral$0.0000.00% ROITEMTempus AI8/8/2025Initiated Coverage$58.74$60.00Buy$00.0000.00% ROIPSNLPersonalis8/6/2025Set Price Target$4.52$6.00$00.0000.00% ROITEMTempus AI4/21/2025Initiated Coverage$40.42$60.00Buy$00.0000.00% ROIMXCTMaxCyte3/12/2025Set Price Target$3.47$6.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenCitigroupUBS GroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.